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Abstract
Background: Viperid snakebite envenoming is characterized by prominent local tissue damage, including muscle necrosis.
A frequent outcome of such local pathology is deficient skeletal muscle regeneration, which causes muscle dysfunction,
muscle loss and fibrosis, thus provoking permanent sequelae that greatly affect the quality of life of patients. The causes of
such poor regenerative outcome of skeletal muscle after viperid snakebites are not fully understood.
Methodology/Principal Findings: A murine model of muscle necrosis and regeneration was adapted to study the effects of
the venom and isolated toxins of Bothrops asper, the medically most important snake in Central America. Gastrocnemius
muscle was injected with either B. asper venom, a myotoxic phospholipase A2 (Mtx), a hemorrhagic metalloproteinase
(SVMP), or saline solution. At various time intervals, during one month, tissue samples were collected and analyzed by
histology, and by immunocytochemical and immunohistochemical techniques aimed at detecting muscle fibers, collagen,
endothelial cells, myoblasts, myotubes, macrophages, TUNEL-positive nuclei, and axons. A successful regenerative response
was observed in muscle injected with Mtx, which induces myonecrosis but does not affect the microvasculature. In contrast,
poor regeneration, with fibrosis and atrophic fibers, occurred when muscle was injected with venom or SVMP, both of
which provoke necrosis, microvascular damage leading to hemorrhage, and poor axonal regeneration.
Conclusions/Significance: The deficient skeletal muscle regeneration after injection of B. asper venom is likely to depend on
the widespread damage to the microvasculature, which affects the removal of necrotic debris by phagocytes, and the
provision of nutrients and oxygen required for regeneration. In addition, deficient axonal regeneration is likely to contribute
to the poor regenerative outcome in this model.
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Introduction
Snakebite envenomings constitute a highly relevant and neg-
lected public health problem on a world wide basis, affecting
particularly the rural settings of Latin America, Africa and Asia
[1–3]. In Latin America, the majority of snakebites are inflicted
by species classified in the genus Bothrops [4,5]. These envenom-
ings are characterized by complex pathological and pathophys-
iological profiles that include prominent local tissue damage,
i.e. necrosis, hemorrhage, blistering and edema, and systemic
alterations, i.e. bleeding, coagulopathy, cardiovascular shock and
renal failure [6–10]. Among these effects, local tissue damage
leading to necrosis is particularly relevant, since it is frequently
followed by poor tissue regeneration, with the occurrence of
permanent sequelae associated with tissue loss and dysfunction,
and their consequent social and psychological implications
[1,11,12].
Skeletal muscle regeneration is a complex and finely orches-
trated process that involves the interaction of myogenic cells, other
resident cells, inflammatory cells, blood vessels, nerves and
extracellular matrix [13]. It starts after the injury of muscle fibers,
with the activation of a population of quiescent myogenic cells,
satellite cells, located at the periphery of the fibers between muscle
sarcolemma and the basement membrane [13–15]. Once
activated, satellite cells become myoblasts which, after various
cycles of replication, undergo a process of cell fusion leading to the
formation of multinucleated myotubes which then mature to
become adult myofibers [16]. For this process to proceed
successfully, several requirements must be met in the microenvi-
ronment where regeneration takes place. After muscle fiber ne-
crosis, an inflammatory reaction ensues, with invasion of the tissue
by neutrophils and macrophages. Besides removing necrotic
debris, these cells, especially macrophages, synthesize various cyto-
kines and growth factors which modulate the tissue regenerative
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Furthermore, an intact microvascular supply is required for
regeneration [13], together with a restitution of the neuromuscular
junction in the regenerative fibers [18]. The persistence of a
structurally intact basement membrane around necrotic muscles is
also important for the demarcation of the space where myoblast
replication and fusion occurs [13,19]. Various muscle pathologies
are associated with a good regenerative outcome, especially in
conditions where blood supply and innervation are not affected,
whereas in other diseases, such as ischemic lesions and some
muscular dystrophies, regeneration is deficient [13,20]. Unveiling
the factors associated with deficient muscle regeneration in various
diseases, including snakebite envenoming, is highly relevant for the
design of interventions aimed at improving this process.
In the case of snake venom-induced myonecrosis, two clearly
different patterns of regeneration have been described: when tissue
is affected by venoms or toxins that induce muscle necrosis but do
not affect the integrity of blood vessels, such as after injection of
isolated myotoxic phospholipases A2 (PLA2) or cardiotoxins,
regeneration proceeds successfully [21–23]. Some of these
myotoxins have been used as models to investigate particular
aspects of muscle regeneration [21]. In contrast, when muscle is
affected by venoms which, in addition to affecting muscle fibers
also damage the microvasculature, inducing hemorrhage, such as
many viperid snake venoms, the regenerative process is impaired,
with substitution of muscle tissue by fibrosis in some areas, and
with the presence of regenerating fibers of reduced diameter
[22,24–26]. In the case of Bothrops sp venoms, these experimental
observations constitute an excellent correlate of the clinical
situation, where tissue loss and dysfunction are common
consequences of these envenomings [6,7,9].
From the medical standpoint Bothrops asper is the most important
snake in southern Mexico, Central America and northern areas of
South America [5,27]. Envenomings by this species are associated
with local tissue damage which often leads to sequelae associated
with impaired muscle regeneration [6,7,9]. Such phenomenon has
been investigated at the experimental level, and it has been
proposed that microvascular damage provoked by hemorrhagic
snake venom metalloproteinases (SVMPs) is a key factor in the
poor regenerative outcome [22,24,28]. However, the majority of
these studies have been based on a qualitative histological
assessment of tissue alterations; moreover, other factors, such as
damage to nerves and myogenic cells, have not been studied. It is
necessary, therefore, to further investigate this phenomenon from
a quantitative perspective, and to assess the participation of
various factors involved in tissue damage and repair, in order to
identify the critical processes being affected that preclude a
successful regenerative outcome. This study examined, using a
combination of qualitative and quantitative approaches, the
skeletal muscle regeneration in murine skeletal muscle injected
with the venom of B. asper, and with some purified toxins. It was
found that critical events occur within the first days after tissue
necrosis, with microvascular damage occupying a central role in
the stage. In addition, a poor regeneration of axons is described,
which is likely to affect muscle regeneration. The characterization
of this deficient regenerative scenario may become a useful
experimental model to assess interventions aimed at improving the
process of muscle regeneration in this and related pathologies.
Methods
Animals, venoms and toxins
Mice (CD1, 18–20 g body weight) were used throughout the
study. Venom was obtained from a collection of adult B. asper
specimens from the Pacific versant of Costa Rica, maintained at
the serpentarium of Instituto Clodomiro Picado. Immediately after
collection, venom was lyophilized and stored at 220uC. The
hemorrhagic SVMP BaP1 was isolated from this venom, as
previously described [29,30]. A myotoxic fraction (Mtx) was
isolated from this venom by ion-exchange chromatography on
CM-Sephadex C-50 [31]. This fraction was a mixture of the two
types of basic myotoxins present in the venom, i.e. a catalytically-
active Asp49 PLA2 and a catalytically-inactive PLA2 homologue,
in a 1:2 approximate molar ratio, which roughly corresponds to
the proportion of these types of myotoxins in the venom [32]. This
myotoxic fraction was utilized in order to reproduce the combined
action of these molecules in the crude venom, since a synergistic
effect has been described for these Asp49 and Lys49 myotoxic
PLA2s [33]. Venom and toxin solutions were prepared in 0.14 M
NaCl, 0.04 M phosphate, pH 7.2, solution (PBS) immediately
before use.
Ethics statement
The experimental protocols involving the use of animals in this
study were approved by the Institutional Committee for the Care
and Use of Laboratory Animals (CICUA) of the University of
Costa Rica (protocol CICUA-27-10) and adhere to the Interna-
tional Guiding Principles for Biomedical Research Involving
Animals of the Council of International Organizations of Medical
Sciences (CIOMS).
Histological analysis
Mice were injected intramuscularly, in the right gastrocnemius,
with either crude venom (50 mg), Mtx (100 mg), or BaP1 (50 mg),
dissolved in 50 ml of PBS. These doses were selected since they
induce a similar extent of tissue damage [22,24]. Muscles injected
with PBS under otherwise identical conditions were used as
controls. For histological analysis, mice were sacrificed at different
times (1 and 6 hr, and 1, 3, 7, 14 and 28 days) and the injected
gastrocnemius muscles were dissected out and placed in a zinc
fixative solution (BD Pharmigen, USA), for at least 48 hours at
4uC. These time intervals were selected because they cover the
acute phase of tissue damage (1 and 6 hr), the inflammatory
reaction following necrosis (1 and 3 days), and the various steps in
the process of muscle regeneration (3, 7, 14 and 28 days) [22,24].
The tissue was then dehydrated in ethanol, placed in xylene, and
embedded in paraffin using conventional protocols [34]. For
quantitative assessment of tissue changes, three non-consecutive
sections of 4 mm were obtained from the mid-belly region of each
muscle, placed in glass slides, deparaffinized in xylene, hydrated in
distilled water and stained with hematoxylin and eosin for
microscopic evaluation. Three images were captured from each
section using an Evolution MP camera (Media Cybernetics, USA).
The extent of necrosis was estimated in samples collected 24 hr
after injection as the percentage of the examined area corre-
sponding to necrotic fibers, which were identified by characteristic
morphological alterations, i.e. hypercontraction or coagulative
necrosis. The extent of regeneration was estimated in samples
collected at 28 days as the percentage of the examined area
corresponding to regenerating fibers, i.e. fibers having a centrally-
located nuclei. In addition, the diameters of regenerating fibers in
tissue samples collected 28 days after injection were determined.
Both types of analyses were performed using an image analysis
software (Image Pro 6.3, Media Cybernetics, USA).
Sirius Red staining of collagen
Groups of three mice were injected in the right gastrocnemius
muscle with either PBS, venom, Mtx or BaP1, at the doses
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order to detect fibrosis, i.e. increments in collagen in the tissue,
sections were stained with Sirius Red dye CI 35780 (Polyscience
Inc, USA), which stains collagen. The procedure described by
Montes and Junqueira [35] was followed, with some modifications.
In brief, sections were stained with picro Sirius red (0.1% in a
saturated picric acid solution) and Fast Green FCF 0.1% (for
staining proteins) (Sigma, USA), for one hr at room temperature.
The slides were washed twice with acidified water (5 ml of glacial
acetic acid per liter), dehydrated, cleared in xylene and mounted
(Shandon Xylene Substitute Mountant, Thermo Scientific, USA).
Changes in the capillary density and the capillary/muscle
fiber ratio
Groups of three mice were injected in the right gastrocnemius
muscle with crude venom (50 mg), dissolved in 50 ml of PBS, and
sacrificed at various time intervals covering the degenerative and
the regenerative phases (1 and 6 hr, and 1, 3, 7, 14 and 28 days).
In some experiments, groups of mice were injected with 100 mg
Mtx, and sacrificed at 24 hr and 28 days. Control muscles were
obtained from groups of mice injected with 50 ml of PBS at all time
intervals studied. Muscles were dissected out and processed as
described above. Three non-consecutive sections of 4 mm were
obtained per muscle, placed in positive charged glass slides (Erie
Scientific, USA), deparaffinized and hydrated. The detection of
capillary vessels was performed by fluorescence immunohisto-
chemistry. Antigen retrieval was carried out by incubating tissue
sections with Proteinase K (Dako, USA) for 5 min at room
temperature. Blockage steps were performed with avidin and
biotin solutions (Biotin blocking system, Dako Cytomation, USA),
according to the manufacturer’s instructions, as well as with rabbit
immunoglobulins, for 10 min each. Then, sections were incubated
with rat anti-mouse CD31 monoclonal antibody (Cymbus
Biotechnology, USA), at 1:100 dilution for one hr at room
temperature. After washing with PBS, sections were incubated
with polyclonal biotinylated rabbit anti-rat IgG (Dako Cytoma-
tion, Denmark), at 1:200 dilution for one hr at room temperature.
The reaction was amplified using the Tyramide amplification kit
(Perkin Elmer, USA), and finally sections were incubated with a
1:500 dilution of Streptavidin Alexa fluor 488 for one hr at room
temperature. Nuclear staining was performed with DAPI (49,6 9 –
diamino-2-phenylindole, Invitrogen, USA). Three images, from
randomly selected non-overlapping areas, were captured per
section. The total number of capillary vessels, the number of
muscle fibers and the total area of the section were quantified in
each image using the image analysis software described above.
The number of muscle fibers counted per image ranged between
70 and 150, and the total number of muscle fibers counted in the
three images corresponding to each tissue section ranged between
250 and 300. Then, the capillary / muscle cell ratio and the
number of capillaries per area were calculated.
Immunostaining for Pax7 and desmin
Groups of three mice were injected in the right gastrocnemius
with either PBS, venom or Mtx, at the doses described above, and
sacrificed 3, 5 and 7 days after treatment. The identification of
myogenic cells was performed by immunohistochemistry using
antibodies against Pax7 (to detect activated satellite cells/
myoblasts at 3 days) or against desmin (to detect myotubes and
myofibers at 3, 5 and 7 days). Briefly, antigen retrieval was carried
out using citrate buffer, pH 6.0, and heating in microwave oven
for 5 min. Primary mouse anti-human Pax7 antibody (Abcam,
USA), or mouse anti-human desmin antibody (Dako Cytomation,
Denmark) were used at 1:100 dilution and incubated for one hr at
room temperature. Then, sections were incubated with polyclonal
biotinylated goat anti-mouse IgG (Dako Cytomation, Denmark),
at 1:200 dilution for one hr at room temperature. Sections were
then incubated with a 1:500 dilution of Streptavidin Alexa fluor
488 for one hr at room temperature. Three images, from non-
overlapping areas affected by the treatments, i.e. showing necrotic
fibers, fibrosis or regenerating fibers, were captured per muscle
section.
Evaluation of TUNEL-positive nuclei in regenerating
muscle fibers
Groups of three mice were injected in the right gastrocnemius
muscle with either PBS, venom or Mtx, at the doses described
above, and sacrificed 3, 5 and 7 days after treatment. These time
intervals were selected because critical steps involving inflamma-
tory and regenerative events occur during these days in
experimental models of acute muscle damage [13,21]. Three
non-consecutive sections of 4 mm were obtained per muscle, and
were evaluated for the presence of TUNEL-positive cells by using
the ApopTagH Red In Situ Apoptosis Detection Kit (Millipore,
USA), following the protocol described by the manufacturer.
Sections were also immunostained for either Pax7 or desmin, as
described above, to detect activated satellite cells or myotubes and
regenerating myofibers, respectively. Pax7-positive and desmin-
positive cells containing TUNEL-positive nuclei were quantified.
Quantification of nerves in muscle tissue
Groups of five mice were injected in the right gastrocnemius
muscle with either PBS, venom, Mtx or BaP1, at the doses
described above. Animals were sacrificed 3 and 28 days after
injection, in order to detect changes in the density of intramuscular
nerves after the degenerative and regenerative phases, respectively.
Three non-consecutive sections of 4 mm were obtained per muscle,
placed in positive charged glass slides (Erie Scientific, USA),
deparaffinized and hydrated. The immunohistochemical detection
of nerves was performed using a mouse anti-human neurofilament
protein (Dako, Denmark). The staining protocol was similar to
that described for Pax7 and desmin, except for the primary
antibody. Structures of 10–40 mm diameter showing internal fibers
positively stained for neurofilament protein were identified as
intramuscular nerves. The total number of nerves and the area of
muscle tissue examined were determined, in order to estimate the
number of nerves per area. In addition, the number of axons
within nerves was quantified and the axonal density per area of
nerve was determined. Both analyses were performed using the
image analysis software described.
Statistical analysis
Data were analyzed by the statistics software SPSS 15.0. Means,
variance and standard deviation were calculated for each
parameter and treatment, and compared using the Friedman test.
When appropriated, an additional Wilcoxon test was carried out.
Results
Muscle regeneration is deficient in tissue affected by
hemorrhage
Histological observations showed that all treatments, except
PBS, induced evident myonecrosis in the injected gastrocnemius
one day after injection (Fig 1). In the case of muscle injected with
venom or BaP1, hemorrhage was also observed, whereas no
hemorrhage was induced by Mtx. An inflammatory infiltrate was
present in muscles injected with venom or toxins by 1 and 3 days.
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nuclei, were present at 3 days and thereafter, although differences
were noticed among the various treatments. In the case of muscle
injected with Mtx, by 7 days, regenerating fibers were distributed
uniformly in the tissue (Fig 1). In contrast, muscle injected with
venom or BaP1 showed areas of regenerating fibers intermixed
with areas of remnants of necrotic cells, which had very low
numbers of phagocytes, and areas of fibrosis (Fig 1). Therefore, the
histological pattern at 7 days in muscle injected with venom was
characterized by heterogeneity, whereas in the case of tissue
affected by Mtx, a homogeneous pattern predominated (Fig 1).
Fibrosis was corroborated 7 days after injection, by staining with
Sirius Red, in the endomysium and perimysium in muscle injected
with venom or BaP1 (Fig 1), whereas the extent of collagen
deposition was less evident in Mtx-injected muscle, being
nevertheless higher than in PBS-injected muscle. By 28 days,
tissue injected with Mtx presented a pattern of successful
regeneration, with abundant regenerating fibers of similar size
having centrally-located nuclei, and with little fibrosis, albeit with
an increment in the interstitial area as compared with PBS-
injected muscle (Fig 1). In contrast, in the case of muscle injected
with venom or BaP1, which induced hemorrhage, regenerating
fibers of small size were observed, and were intermixed with areas
of fibrosis and, in some cases, with areas in which the remnants of
necrotic fibers had apparently become calcified (Fig 1).
The extent of muscle necrosis and regeneration was quantita-
tively assessed by measuring the area corresponding to necrotic
fibers in gastrocnemius muscle one day after injection of venom or
isolated toxins, and the area of regenerating fibers, i.e. fibers with
centrally located nuclei, 28 days after injection. As shown in Fig 2,
all treatments induced acute muscle damage which ranged from
30% necrotic muscle in the case of SVMP BaP1 to 55% necrotic
muscle in tissue injected with of Mtx. Muscle regeneration was
significantly affected in the case of treatments that induced
hemorrhage besides local myonecrosis, i.e. venom and BaP1
(Fig 2A). In contrast, a successful regeneration was observed in
tissue injected with Mtx alone (Fig 2A). In addition, the diameter
of regenerative fibers 28 days after injection greatly differed among
the various treatments. The diameters of regenerating fibers in
tissue injected with Mtx did not differ from those of control, PBS-
injected muscle fibers (Fig 2B). In contrast, the diameter of
regenerating fibers in tissue treated with either venom or BaP1,
both of which induced hemorrhage, were smaller than those of
control fibers (Fig 2B). On the basis of these results, the rest of the
study was focused mostly on the comparison of two experimental
groups: muscle injected with venom, as a model of poor
regeneration, and muscle injected with Mtx, as a model of
successful regeneration.
B. asper venom induces rapid damage to capillary vessels
followed by revascularization
Injection of B. asper venom, at a dose that induces prominent
hemorrhage, resulted in a drastic and rapid drop in the number of
capillary vessels in gastrocnemius muscle, as judged both by the
Figure 1. Light micrographs of sections of mouse skeletal muscle at 1, 7 and 28 days after the injection, in the gastrocnemius
muscle, of phosphate-buffered saline solution (PBS), B. asper venom, Myotoxin (Mtx), and metalloproteinase BaP1. First, second and
fourth horizontal rows of figures correspond to hematoxylin-eosin-stained sections, whereas the third row corresponds to sections stained with Sirius
Red and counterstained with Fast Green FCF. Bar represents 100 mm.
doi:10.1371/journal.pone.0019834.g001
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PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e19834Figure 2. (A) Quantitative assessment of the extent of myonecrosis and regeneration in mouse gastrocnemius muscle injected with either B. asper
venom, Mtx or BaP1. Histological sections stained with hematoxylin and eosin were analyzed one and 28 days after injections. The extent of necrosis
was estimated in samples collected one day after injection as the percentage of the examined area corresponding to necrotic fibers, whereas the
extent of regeneration was estimated in samples collected at 28 days as the percentage of the examined area corresponding to regenerating fibers,
i.e. fibers having centrally-located nuclei. *p , 0.05 when comparing the percentage of necrosis and of regeneration for a single treatment.
(B) Quantitative assessment of the diameter of regenerating muscle fibers, i.e. fibers presenting centrally-located nuclei, 28 days after intramuscular
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tissue area. Both parameters of capillary density remained signifi-
cantly reduced, when compared with control values, during the first
week (Fig 3A and B). Muscle injected with PBS had a normal pattern
of capillaries, as evidenced by immunostaining for CD31 (Fig 3C).
A spatially heterogeneous pattern of capillary damage was observed
rapidly after venom injection (Fig 3D). The number of capillaries in-
creased by 7 days (Fig 3A, B and E) and reached values similar to
those of control tissue by 14 and 28 days (Fig 3A and B), thus eviden-
cing a revascularization process. In contrast, when Mtx was admini-
stered, the number of capillaries was not affected (results not shown),
in agreement with the lack of hemorrhagic activity of this toxin.
A spatially heterogeneous pattern of regenerating fibers
with TUNEL-positive nuclei was observed in muscle
treated with venom
As described above, both histological and immunohistochemical
analyses evidenced profound differences during the first 7 days
after injection between muscles treated with Mtx and those
injected with venom. Thus, it is likely that critical events occur
during these early stages in the reparative and regenerative
scenario. In order to assess whether myogenic and regenerating
fibers undergo cell damage, tissue sections were stained with
TUNEL, together with Pax7 or desmin, which are markers of
activated satellite cells/myoblasts and regenerating muscle cells,
respectively [36]. No significant differences were observed in the
number of Pax7-positive cells per area, at 3 days, between muscles
injected with venom and with Mtx (not shown), thus revealing a
similar extent of activation of satellite cells after these treatments.
Moreover, there were no significant differences in the percentage
of Pax7-positive cells showing positive TUNEL staining at this
time interval (venom: 7.364.9 %; Mtx: 4.362.4 % (mean6SEM,
n=9); p . 0.05). When the percentage of desmin-positive cells
having at least one TUNEL-positive nucleus was quantified, no
significant differences were observed between treatments at 3, 5
and 7 days, despite a trend showing more TUNEL-positive nuclei
injection in the gastrocnemius of PBS, B. asper venom, Mtx or BaP1. Regenerating fibers in tissue injected with venom and BaP1 showed a reduced
diameter when compared with control fibers in tissue injected with PBS (p , 0.05), whereas no significant difference was observed in the diameter of
regenerating fibers in muscle injected with Mtx (p . 0.05). In both graphs, results are presented as mean6SD (n=9).
doi:10.1371/journal.pone.0019834.g002
Figure 3. Time-course of changes in capillary/muscle fiber ratio (A) and in capillary density (capillaries per mm
2, B) in mouse
gastrocnemius muscle injected with B. asper venom; control mice were injected with PBS. Capillaries were visualized by
immunohistochemistry with a rat anti-mouse CD31 monoclonal antibody, as described in Materials and Methods. A reduction in both parameters
of capillary density occurred rapidly after venom injection, followed by a revascularization process. Results are presented as mean6SD (n=9). * p ,
0.05 when compared with capillary/muscle cell ratio and capillary density of muscle injected with PBS. (C–E) Immunohistochemical staining of
endothelial cells in sections of mouse gastrocnemius muscle one day after injection of PBS (C), or one day (D) and seven days (E) after injection of
B. asper venom. Endothelial cells were detected with anti-CD31 antibody, followed by a polyclonal biotinylated rabbit anti-rat IgG and Streptavidin
Alexa fluor 488 (see Methods for details). Notice the loss of endothelial cell immunostaining in some areas in muscle injected with venom (asterisk).
Bar represents 50 mm.
doi:10.1371/journal.pone.0019834.g003
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tissue sections revealed a noticeable spatial heterogeneity in the
pattern of TUNEL staining, especially in muscle injected with
venom, since there were areas in which many myonuclei were
TUNEL-positive, whereas this staining was lower or largely absent
in other areas in venom-injected and, especially in Mtx-injected
tissue (Fig 4B, C and D).
Intramuscular nerves are affected by venom, Mtx and
BaP1
Since an adequate innervation is a requisite for successful
muscle regeneration, the integrity of intramuscular nerves was
assessed by immunostaining with anti-neurofilament protein. A
similar drop in nerve density was observed at 3 days in tissue
injected with either venom, Mtx or BaP1, as compared with tissue
injected with PBS (Fig 5A), thus reflecting acute damage to axons.
A reduction in the density of nerves in control samples injected
with PBS was observed at 28 days, as compared with 3 days,
probably reflecting the normal growth of muscle tissue in mice.
The number of nerves per area showing immunostained axons in
tissue injected with venom, Mtx or BaP1 increased at 28 days, as
compared with the same treatments at 3 days, and no difference
was detected between control muscle and muscles injected with
venom, Mtx or BaP1 at 28 days (Fig 5A). However, a conspicuous
difference was noticed in the density of axons within nerves in the
various treatments observed in immunostained sections. At
28 days, the density of axons within nerves was significantly lower
in all treatments, as compared with muscle injected with PBS (Fig 5
B, C, D, E and F). However, the reduction in axons in venom-
treated muscles was more pronounced than in Mtx-and BaP1-
injected muscle (Fig 5B).
Discussion
Local tissue damage in viperid snakebite envenomings is mainly
due to the action of myotoxic PLA2s and hemorrhagic SVMPs,
with the possible involvement of other components such as
Figure 4. Apoptosis in regenerating skeletal muscle after the injection of either B. asper venom or Mtx. Sections from muscle tissue
samples collected 3, 5 and 7 days after injection of venom or Mtx were immunostained with anti-desmin antibodies and with TUNEL (see Methods for
details). (A) The percentage of desmin-positive regenerating muscle fibers showing at least one TUNEL-positive nuclei, in relation to the total number
of desmin-positive regenerating muscle fibers, was estimated. Results are presented as mean6SD (n=9). (B) TUNEL-positive nuclei in desmin-positive
cells 5 days after injection of either venom or Mtx. To highlight the pattern of spatial heterogeneity, each point corresponds to the density of TUNEL-
positive nuclei per area in separate microscopic fields in different areas of the tissue. (C) and (D) Micrographs of muscle tissue sections from mice 5
days after injection of Mtx (C) or B. asper venom (D) immunostained for desmin (green fluorescence) and with TUNEL (reddish coloration in nuclei). No
TUNEL-positive regenerating fibers, showing centrally-located nuclei, are observed in muscle injected with Mtx, whereas several regenerating fibers
present TUNEL-positive nuclei in tissue injected with venom (arrows). Bar represents 50 mm.
doi:10.1371/journal.pone.0019834.g004
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skeletal muscle regeneration is a highly orchestrated phenomenon
whereby resident cells, phagocytic cells and extracellular matrix
interact in a complex scenario. The present work used quantitative
experimental procedures that allowed the study of muscle
regeneration, microvascular density, fibrosis, inflammatory infil-
trate and nerve density, thus providing a greater depth in the
analysis of this model of muscle regeneration. One consistent
finding was that treatments involving the direct damage to the
microvascular network resulting in hemorrhage, i.e. crude venom
Figure 5. (A) Changes in the density of intramuscular nerves in muscle tissue of mice 3 and 28 days after injection of either PBS, B. asper venom, Mtx
or BaP1. Axons in nerves were visualized by immunostaining with a mouse anti-human neurofilament protein, as described in Materials and Methods.
The number of intramuscular nerves per mm
2 of tissue area showing at least one immunostained axon was quantified. Results are presented as
mean6SD (n=5). A significant drop (* p , 0.05) in nerves per area was observed at 3 days in samples injected with either venom, Mtx or BaP1, as
compared to samples injected with PBS, whereas no differences in the number of nerves per area were detected between treatments at 28 days.
(B) Axonal density in intramuscular nerves 28 days after injection of the various agents. The number of axons within each nerve was determined and
expressed in terms of axons per nerve area. Results are presented as mean6SD (n=11). * p , 0.05 when compared with axonal density in control
muscles injected with PBS. **p , 0.05 when compared with axonal density in muscles injected with Mtx. (C to F) Light micrograph sections of mouse
muscle tissue collected 28 days after injection of (C) PBS, (D) B. asper venom, (E) Mtx, and (F) BaP1. Sections were immunostained for neurofilament
protein to detect axons in nerves (arrows). Notice the evident drop in the number of axons in samples from tissue injected with venom or BaP1. Bar
represents 50 mm.
doi:10.1371/journal.pone.0019834.g005
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deficient regenerative response associated with insufficient removal
of necrotic debris, fibrosis and atrophic regenerative fibers. In
contrast, tissue injected with Mtx alone developed acute
myonecrosis without hemorrhage, followed by a largely successful
regenerative process. These observations agree with previous
findings with various snake venoms and toxins evidencing poor
regeneration in conditions where microvascular damage, i.e.
hemorrhage, occurred [22,24–26,28,40].
Our immunohistochemical observations on capillary vessel
density corroborated the rapid damage to the microvasculature
and the subsequent revascularization process. Therefore, it is likely
that the inflammatory reaction that followed acute tissue damage
contributed with angiogenic factors, the nature and source of
which remain to be investigated. Nevertheless, capillary density
remained low during the first days in venom-injected muscle, as
compared with control values and with capillary density in Mtx-
injected muscle. This observation is relevant because critical events
occur in the process of regeneration during those first days,
associated with myoblast replication and fusion [13,36]. Thus, the
concept that particular tissue events have to occur at a proper
‘timing’ is of paramount importance in muscle regeneration. In the
case of muscle injected with hemorrhagic venom, a deficit in
capillary vessel density at critical times during the first days after
necrosis is likely to preclude relevant steps in this process,
regardless of the fact that there is a successful process of
revascularization at later time intervals.
Two main consequences of the acute microvascular damage in
this model are: (a) an impairment of the inflammatory infiltrate in
areas of widespread microvessel damage, and (b) a reduced
supply of oxygen and nutrients to the regenerating tissue in these
areas. The drastic damage to the microvasculature is likely to
preclude the timely arrival of neutrophils and macrophages in
some regions, as shown in this study. This, in turn, may bring at
least two implications: First, there is a deficient removal of
necrotic debris, a phenomenon evidenced by the presence of
remnants of necrotic cells 7 days after venom injection in some
tissue sections. Neutrophils and ‘inflammatory’ CD68 macro-
phages play a key role in necrotic cell removal, and a reduced
population of these inflammatory cells in some affected areas
precludes the completion of this step [17]. Depletion of
neutrophils resulted in a deficient removal of necrotic debris
and impaired regeneration after myonecrosis induced by B. asper
venom and myotoxin in a mouse model [41]. Moreover,
depletion of phagocytic macrophages was associated with a
slower clearance of necrotic debris in a model of freeze injury
[42]. Thus, without a timely removal of necrotic debris by
phagocytosis, regeneration is impaired.
On the other hand, phagocytes, particularly macrophages, are
known to promote muscle regeneration by synthesizing various
mediators in the tissue microenvironment. After removal of
necrotic debris, by neutrophils and ‘inflammatory’ CD68
macrophages, a population of ‘anti-inflammatory’ CD163 macro-
phages invade the tissue 2 to 4 days after injury, releasing anti-
inflammatory cytokines, such as IL-10, and factors that promote
the proliferation and differentiation of myoblasts, including diverse
growth factors and cytokines [13,17,43,44]. The adequate balance
in these mediators determines whether myogenesis or fibrogenesis
predominates [45]. Furthermore, macrophages are known to
prevent myoblasts and myotubes from undergoing apoptosis,
through direct cell-cell interactions mediated by a set of adhesion
molecules [46]. A deficit in this population of CD163 macro-
phages in some areas of damaged muscle would jeopardize the
provision of growth factors and survival signals.
Another consequence of microvascular damage, in the context
of muscle regeneration, is ischemia, with a reduction in the supply
of oxygen and nutrients, which are essential requirements for the
metabolically-demanding regenerative process [13,21]. This does
not occur in tissue injected with myotoxic PLA2s, where capillary
density and blood supply are not impaired [21,22]. The possible
effect of microenvironmental factors favouring apoptosis in
myogenic cells was assessed by TUNEL staining of Pax7 and
desmin-positive cells. No differences occurred in Pax7 cells, thus
suggesting that variations in apoptosis of activated satellite cells/
myoblasts is not the cause of the different regenerative response
between treatments. Moreover, no significant difference was
observed in the overall extent of TUNEL staining in desmin-
positive cells between muscles treated with either Mtx or venom.
Nevertheless, there were areas in venom-injected tissue showing
high numbers of TUNEL-positive myonuclei in regenerating
fibers, suggesting that myonuclei damage is more prone to occur in
some areas, perhaps where the microvasculature is more severely
damaged. There are microenvironmental clues known to promote
apoptosis, such as ischemia or insufficient survival signals, at this
critical window of time in the regenerative process. Apoptotic
nuclei have been described in a number of muscle pathologies,
such as denervation-induced atrophy and dystrophies [47–50].
The observation of tissue areas with abundant TUNEL-positive
nuclei in regenerating fibers, vis-a `-vis the lack of overall
quantitative differences between treatments, underscores the
heterogeneous nature of tissue damage and repair in this model.
This supports the concept that a proper analysis of these
phenomena should consider, in addition to the overall quantitative
tissue changes, the qualitative assessment of this heterogeneous
pattern [51].
Another significant difference between muscle regeneration in
tissue injected with venom, BaP1 or Mtx is the abnormally small
diameter of regenerating fibers in the former two treatments. This
observation may reveal the presence of atrophic fibers, since
although the first stages in myoblast replication and fusion do not
require an intact nerve supply [13], the further growth of
regenerating fibers is dependent on a functional innervation
[21,52]. Quantification of nerves by immunostaining with
neurofilament protein revealed a drastic reduction at 3 days. This
observation indicates that both Mtx and BaP1, and consequently
venom as well, affect the integrity of axons in intramuscular
nerves. Despite the fact that Bothrops sp myotoxic PLA2s do not
exert a systemic neurotoxic effect, they are known to affect
transmission in nerve-muscle preparations [53,54], suggesting that
direct contact of these myotoxins with nerve terminals may result
in axonal damage, as occurs with typical neurotoxic PLA2s [55].
Moreover, the products of phospholipids hydrolysis, i.e. lysopho-
spholipid and fatty acids, are capable of affecting the integrity of
nerve terminals [56]. Thus, B. asper myotoxic PLA2s are likely to
damage the integrity of axons. Intramuscular nerve axonal
damage after injection of Bothrops sp venoms has been previously
documented [24,57]. BaP1 also induced nerve damage, indicating
that this effect is caused by SVMPs as well. Alternatively, axonal
damage after injection of BaP1 and venom might be secondary to
ischemia resultant from SVMP-induced microvessel pathology.
Nerve damage was followed by axon regeneration, as demon-
strated by the increment of structures showing positive immuno-
staining for neurofilament protein by 28 days. However, although
the total number of nerves was similar at this time interval in
venom-, BaP1- and Mtx-injected muscles, the density of axons in
each nerve was evidently reduced in tissue affected by these three
agents, particularly by venom, suggesting that there might be other
venom components, in addition to Mtx and BaP1, which may
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axonal regeneration in venom and BaP1-treated muscle might be
a consequence of the effect of SVMPs on the integrity of the basal
lamina of nerves. It has been shown that when such extracellular
matrix structure is damaged, reinnervation of muscle is poor [18].
Such SVMP-induced damage to basal lamina may affect various
components including agrin, a heparan sulphate proteoglycan that
plays a key role in axon growth and the formation of neuro-
muscular junctions [18]. In the case of Mtx-induced axonal
damage, the preservation of basal lamina is likely to contribute to a
more complete reinnervation, albeit even in this case the axonal
density within nerves is still lower than in control samples 28 days
after injection.
An alternative mechanism explaining the presence of small
regenerating fibers in venom-affected muscle may be associated
with SVMP-induced damage to the basement membrane
surrounding muscle fibers. The integrity of such extracellular
matrix scaffold during regeneration is highly relevant, since
myoblasts proliferate and fuse within the space delimited by the
basement membrane of necrotic fibers, therefore ensuring an
orderly restitution of tissue architecture [13,19]. SVMPs are
known to hydrolyze basement membrane components in vitro
[58,59] and in vivo [59,60]. When proliferating myoblasts are not
confined to the space delimited by the basement membrane, they
may proliferate outside such space. In these conditions, fewer cells
would undergo fusion and, consequently, small caliber myotubes
and myofibers would be generated [13]. Further studies are
required to assess the role of SVMP-induced degradation of
muscle fiber basement membrane in the process of muscle
regeneration. It is hypothesized that the presence of atrophic
regenerating fibers in tissue injected with venom is predominantly
a consequence of SVMP damage to the basement membrane
components of nerves and muscle.
In conclusion, our results show that skeletal muscle regeneration
is partially deficient after acute tissue damage induced by the
injection of B. asper venom and by a hemorrhagic SVMP, whereas
a successful regenerative response occurs after myonecrosis
induced by a myotoxin which affects muscle fibers but not the
microvasculature nor the basement membranes of muscle fibers
and nerves. These results support the hypothesis that SVMP-
induced basement membrane damage, in microvessels, muscle
fibers and nerves, is the main culprit for the poor regenerative
outcome in this model. Damage to the microvasculature is likely to
induce ischemia and to affect the arrival of phagocytic cells in
some necrotic areas. In addition, axonal regeneration is impaired.
As a consequence of this complex tissue scenario, fibrosis
substitutes muscle tissue in some areas, and the diameter of
regenerating fibers is abnormally small. These observations
reproduce clinical findings and provide an experimental frame
to assess the mechanisms involved in such poor regenerative
outcome and to test therapeutic interventions aimed at improving
muscle regeneration in people suffering from snakebite envenom-
ing. Moreover, our findings underscore the potential usefulness of
inhibiting SVMPs in situ after venom injection, in order to prevent
tissue damage and to facilitate regeneration. Since similar
pathological effects are induced by many viperid snake venoms
in different parts of the world, our observations and conclusions
may have broader implications in the context of snakebite
envenoming.
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